MedTrace Logo

Association of a HABIT-ILE Course and a Home Programme on the Bimanual Performance of Children With Cerebral Palsy

NCT06963151 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-04-15

No results posted yet for this study

Summary

This non-inferiority, mixed-methods, multicentre randomised controlled trial will compare the effects of functional changes and families' resources at 3 months of the PARTNER programme (35h HABIT-ILE + 15h home programme) with the reference HABIT-ILE programme (50h) on the bimanual performance (Assisting Hand Assessment \[AHA\]) of 66 children with unilateral CP aged 3 to 5 years.

Conditions

  • Cerebral Palsy

Interventions

OTHER

Behavioral: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities

* Structured bimanual tasks training, with gradual increase in motor difficulty, requiring increased postural adjustments and the use of the lower extremities. * Home programme with parental coaching

OTHER

Behavioral: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities

\- Structured bimanual tasks training, with gradual increase in motor difficulty, requiring increased postural adjustments and the use of the lower extremities.

Sponsors & Collaborators

  • University Hospital, Angers

    collaborator OTHER_GOV

  • LP3C, University of Rennes 2

    collaborator UNKNOWN

  • Claude Bernard University

    collaborator OTHER

  • IMT Atlantique Brest

    collaborator UNKNOWN

  • INSERM UMR 1101

    collaborator UNKNOWN

  • Fondation Ildys

    lead OTHER

Principal Investigators

  • Rodolphe BAILLY · Fondation Ildys

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-01
Primary Completion
2029-09-01
Completion
2029-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06963151 on ClinicalTrials.gov